Dutch Epilepsy Clinics Foundation Report issue

Foundation

Organization Overview

First Clinical Trial
2003
NCT00208520
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3